{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:11:32Z","timestamp":1767651092811,"version":"build-2065373602"},"reference-count":224,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.hoc.2004.09.008","type":"journal-article","created":{"date-parts":[[2005,4,23]],"date-time":"2005-04-23T07:59:38Z","timestamp":1114243178000},"page":"147-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Thrombolytic Therapy: Current Clinical Practice"],"prefix":"10.1016","volume":"19","author":[{"suffix":"Jr","given":"William F.","family":"Baker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2004.09.008_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1172\/JCI103887","article-title":"The maintenance of a sustained thrombolytic state in man: II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders","volume":"38","author":"Fletcher","year":"1959","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hoc.2004.09.008_bib2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jacc.2004.07.002","volume":"44","author":"Antman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib3","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.STR.0000064841.47697.22","article-title":"Guidelines for the early management of patients with ischemic stroke: a scientific statement from the stroke council of the American Stroke Association","volume":"34","author":"Adams","year":"2003","journal-title":"Stroke"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2004.09.008_bib4","doi-asserted-by":"crossref","first-page":"300S","DOI":"10.1378\/chest.119.1_suppl.300S","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke","volume":"119","author":"Albers","year":"2001","journal-title":"Chest"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2004.09.008_bib5","doi-asserted-by":"crossref","first-page":"253S","DOI":"10.1378\/chest.119.1_suppl.253S","article-title":"Intravenous thrombolysis in acute myocardial infarction","volume":"119","author":"Ohman","year":"2001","journal-title":"Chest"},{"issue":"Suppl","key":"10.1016\/j.hoc.2004.09.008_bib6","first-page":"10","article-title":"The fibrinolytic system","volume":"49","author":"McNicol","year":"1973","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.hoc.2004.09.008_bib7","series-title":"Disorders of hemostasis and thrombosis: clinical and laboratory practice","first-page":"1","article-title":"Physiology of hemostasis","author":"Bick","year":"1992"},{"key":"10.1016\/j.hoc.2004.09.008_bib8","series-title":"Disorders of hemostasis and thrombosis: principles of clinical practice","first-page":"1","article-title":"Physiology of hemostasis and thrombosis","author":"Bick","year":"1985"},{"key":"10.1016\/j.hoc.2004.09.008_bib9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1172\/JCI108784","article-title":"The behavior of alpha-2-plasmin inhibitor in fibrinolytic states","volume":"60","author":"Aoki","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hoc.2004.09.008_bib10","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0002-8703(99)70400-X","article-title":"Safety assessment of a single bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial","volume":"137","author":"Van de Werf","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.hoc.2004.09.008_bib11","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0140-6736(99)07403-6","article-title":"Single bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomized trial","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2004.09.008_bib12","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1161\/01.CIR.98.25.2805","article-title":"TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction. Results of the TIMI 10B trial","volume":"98","author":"Cannon","year":"1998","journal-title":"Circulation"},{"issue":"1 Pt 1","key":"10.1016\/j.hoc.2004.09.008_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.RVI.0000112621.22203.12","article-title":"Catheter-directed thrombolytic therapy for limb ischemia: current status and controversies","volume":"15","author":"Razavi","year":"2004","journal-title":"J Vasc Interv Radiol"},{"issue":"Suppl 2","key":"10.1016\/j.hoc.2004.09.008_bib14","first-page":"S25","article-title":"Pharmacologic and clinical characteristics of thrombolytic agents","volume":"3","author":"Deitcher","year":"2002","journal-title":"Rev Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.hoc.2004.09.008_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/hrt.2003.019877","article-title":"Adjunctive treatment in patients treated with thrombolytic therapy","volume":"90","author":"Brouwer","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.hoc.2004.09.008_bib16","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1161\/01.CIR.98.23.2527","article-title":"Thrombolytic therapy in acute myocardial infarction: comparison of procoagulant effects of streptokinase and alteplase regimens with focus on kallikrein system and plasmin","volume":"98","author":"Hoffmeister","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0140-6736(90)90720-P","article-title":"Promotion of thrombin activity by thrombolytic therapy without simultaneous anticoagulation","volume":"1","author":"Rapold","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2004.09.008_bib18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0735-1097(87)80194-8","article-title":"Paradoxic elevation of fibrinopeptide A after streptokinase: evidence for continued thrombosis despite fibinolysis","volume":"10","author":"Eisenberg","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/01.CIR.91.1.28","article-title":"Plasmin-mediated activation of the contact system in response to pharmacological thrombolysis","volume":"91","author":"Ewald","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0268-9499(91)90003-M","article-title":"Factors responsible for the differential procoagulant effects of diverse plasminogen activators in plasma","volume":"5","author":"Eisenberg","year":"1991","journal-title":"Fibrinolysis"},{"issue":"7","key":"10.1016\/j.hoc.2004.09.008_bib21","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.amjcard.2003.12.017","article-title":"Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarction","volume":"93","author":"Merlini","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib22","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/01.CIR.73.3.418","article-title":"Intra-myocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death","volume":"73","author":"Davies","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib23","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1161\/01.CIR.89.4.1802","article-title":"Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improves thrombolysis","volume":"89","author":"Nicolini","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0022-3565(25)10298-X","article-title":"Effects of heparin, aspirin, and synthetic glycoprotein IIb\/IIIa receptor antagonist on coronary reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dog","volume":"264","author":"Roux","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.hoc.2004.09.008_bib25","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.CIR.95.4.846","article-title":"Combined accelerated tissue-plasminogen activator and glycoprotein IIb\/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction: results of a randomized, placebo-controlled dose-ranging trial","volume":"95","author":"Ohman","year":"1997","journal-title":"Circulation"},{"issue":"Suppl I","key":"10.1016\/j.hoc.2004.09.008_bib26","first-page":"I553","article-title":"More complete and stable reperfusion with platelet IIb\/IIIa antagonism plus thrombolysis for AMI: the PARADIGM trial [abstract]","volume":"94","author":"Moliterno","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00005344-199402000-00004","article-title":"Prevention of rethrombosis after coronary thrombolysis in chronic canine model: adjunctive therapy with monoclonal antibody 7E3 F(ab\u2032) 2 fragment","volume":"23","author":"Rote","year":"1994","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.hoc.2004.09.008_bib28","first-page":"474","article-title":"Effect of fibrinolysis on adhesion and aggregation of human platelets","volume":"19","author":"Cronberg","year":"1968","journal-title":"Thromb Diathesis Haemorrhage"},{"issue":"6","key":"10.1016\/j.hoc.2004.09.008_bib29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/cvr\/24.6.471","article-title":"Effects of streptokinase, urokinase, and recombinant tissue plasminogen activator on platelet aggregability and stability of platelet aggregates","volume":"24","author":"Terres","year":"1990","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hoc.2004.09.008_bib30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.CIR.77.1.142","article-title":"Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction","volume":"77","author":"Fitzgerald","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib31","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1055\/s-0037-1615382","article-title":"Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction","volume":"80","author":"Nordt","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2004.09.008_bib32","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/S0735-1097(98)00172-7","article-title":"Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment","volume":"31","author":"Gurbel","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib33","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.101.23.2690","article-title":"High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (Thrombolysis in Myocardial Infarction) 14","volume":"101","author":"Coulter","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib34","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.1912.04270120001001","article-title":"Clinical features of sudden obstruction of the coronary arteries","volume":"59","author":"Herrick","year":"1912","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2004.09.008_bib35","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM198010163031601","article-title":"Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction","volume":"303","author":"DeWood","year":"1980","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.hoc.2004.09.008_bib36","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.291.6.736","article-title":"Primary coronary intervention for acute myocardial infarction","volume":"291","author":"Keeley","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2004.09.008_bib37","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJM199706053362301","article-title":"A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2004.09.008_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0735-1097(03)00506-0","article-title":"Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the thrombolysis in myocardial infarction trials","volume":"42","author":"Gibson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.hoc.2004.09.008_bib40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0965-2302(03)00062-6","article-title":"Improving door-to-drug time and ST segment resolution in AMI by moving thrombolysis administration to the emergency department","volume":"12","author":"McLean","year":"2004","journal-title":"Accid Emerg Nurs"},{"key":"10.1016\/j.hoc.2004.09.008_bib41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2004.09.008_bib42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.CIR.76.1.142","article-title":"Thrombolysis in Acute Myocardial Infarction (TIMI) trial, phase 1: a comparison between intravenous plasminogen activator and intravenous streptokinase","volume":"76","author":"Chesebro","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib43","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0140-6736(85)92208-1","article-title":"Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction","volume":"1","author":"Verstraete","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2004.09.008_bib44","first-page":"956","article-title":"Double blind randomized trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction","volume":"2","author":"Verstraete","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2004.09.008_bib45","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.CIR.75.4.817","article-title":"The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streprokinase from the thrombolysis in myocardial infarction (TIMI phase I) trial","volume":"75","author":"Sheehan","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib46","first-page":"863","article-title":"Randomized double-blind trial of recombinant prourokinase against streptokinase in acute myocardial infarction","volume":"1","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2004.09.008_bib47","first-page":"397","article-title":"Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction","volume":"1","year":"1986","journal-title":"Lancet"},{"issue":"6 Suppl A","key":"10.1016\/j.hoc.2004.09.008_bib48","first-page":"3A","article-title":"Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction","volume":"12","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib49","first-page":"545","article-title":"Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of placebo-controlled clinical trial","volume":"1","year":"1988","journal-title":"Lancet"},{"issue":"8610","key":"10.1016\/j.hoc.2004.09.008_bib50","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(88)92656-6","article-title":"Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavia study of early thrombolysis (ASSET)","volume":"2","author":"Wilcox","year":"1988","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.hoc.2004.09.008_bib51","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1001\/jama.283.20.2686","article-title":"Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis","volume":"283","author":"Morrison","year":"2000","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.hoc.2004.09.008_bib52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.resuscitation.2003.12.016","article-title":"Long-term survival and neurological outcome of patients who received recombinant tissue plasminogen activator during out-of-hospital cardiac arrest","volume":"61","author":"Lederer","year":"2004","journal-title":"Resuscitation"},{"issue":"1","key":"10.1016\/j.hoc.2004.09.008_bib53","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1362-1017.2004.0044.x","article-title":"Nurse-initiated thrombolysis: a systematic review of the literature","volume":"9","author":"Smallwood","year":"2004","journal-title":"Nurs Crit Care"},{"issue":"6","key":"10.1016\/j.hoc.2004.09.008_bib54","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.whi.2003.09.002","article-title":"Presentation, delay, and contraindication to thrombolytic treatment in females and males with myocardial infarction","volume":"13","author":"Grace","year":"2003","journal-title":"Womens Health Issues"},{"issue":"3","key":"10.1016\/j.hoc.2004.09.008_bib55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajem.2004.02.005","article-title":"Fibrinolytic administration for acute myocardial infarction in a tertiary ED: factors associated with an increased door-to-needle time","volume":"22","author":"Zed","year":"2004","journal-title":"Am J Emerg Med"},{"issue":"23","key":"10.1016\/j.hoc.2004.09.008_bib56","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1161\/01.CIR.0000103122.10021.F2","article-title":"Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial","volume":"108","author":"Steg","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hoc.2004.09.008_bib57","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0033-0620(00)70007-7","article-title":"Does an open infarct-related artery after myocardial infarction improve electrical stability?","volume":"42","author":"Carnendran","year":"2000","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.hoc.2004.09.008_bib58","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0735-1097(99)00351-4","article-title":"Update: ACC\/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)","volume":"34","author":"Ryan","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib59","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0735-1097(98)00395-7","article-title":"Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty","volume":"32","author":"Brodie","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib60","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0002-9149(01)02039-2","article-title":"Importance of tome to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction","volume":"88","author":"Brodie","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib61","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1161\/01.CIR.0000091088.63921.8C","article-title":"Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction","volume":"108","author":"Dalby","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib62","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1161\/01.CIR.86.6.1710","article-title":"A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction","volume":"86","author":"O'Neill","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib63","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/euhj.1999.1993","article-title":"Multicenter randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory","volume":"21","author":"Widimsky","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hoc.2004.09.008_bib64","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/hrt.82.4.426","article-title":"Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities","volume":"82","author":"Vermeer","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.hoc.2004.09.008_bib65","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/S0735-1097(99)00444-1","article-title":"A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction","volume":"34","author":"Ross","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hoc.2004.09.008_bib66","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ajem.2003.09.001","article-title":"The evolution of thrombolytic therapy and adjunctive antithrombotic regimens in acute ST-segment elevation myocardial infarction","volume":"22","author":"Cohen","year":"2004","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.hoc.2004.09.008_bib67","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0195-668X(02)00618-8","article-title":"Management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"24","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hoc.2004.09.008_bib68","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0002-9149(03)00388-6","article-title":"Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis in Myocardial Infarction (TIMI) time","volume":"91","author":"Juliard","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib69","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/01.CIR.0000126892.17646.83","article-title":"Treatment delayed is treatment denied","volume":"109","author":"Williams","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hoc.2004.09.008_bib70","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0022-510X(89)90060-9","article-title":"Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours","volume":"91","author":"Fieschi","year":"1989","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.hoc.2004.09.008_bib71","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ana.410320113","article-title":"Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke","volume":"32","author":"del Zoppo","year":"1992","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.hoc.2004.09.008_bib72","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3171\/jns.1992.77.3.0337","article-title":"Pathophysiology and treatment of focal cerebral ischemia. Part II: mechanisms of damage and treatment","volume":"77","author":"Siesjo","year":"1992","journal-title":"J Neurosurg"},{"issue":"4","key":"10.1016\/j.hoc.2004.09.008_bib73","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0033-0620(92)90020-Z","article-title":"Thrombolytic therapy in cerebrovascular disorders","volume":"34","author":"Levine","year":"1992","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.hoc.2004.09.008_bib74","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00019052-199402000-00006","article-title":"Thrombolytic therapy for stroke","volume":"7","author":"Brott","year":"1994","journal-title":"Curr Opin Neurol"},{"issue":"12","key":"10.1016\/j.hoc.2004.09.008_bib75","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.STR.23.12.1826","article-title":"Thrombolysis in acute ischemic stroke: does it work?","volume":"23","author":"Wardlaw","year":"1992","journal-title":"Stroke"},{"key":"10.1016\/j.hoc.2004.09.008_bib76","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2004.09.008_bib77","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","article-title":"Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemisperic stroke: the European Cooperative Stroke Study","volume":"274","author":"Hacke","year":"1995","journal-title":"JAMA"},{"issue":"9136","key":"10.1016\/j.hoc.2004.09.008_bib78","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","article-title":"Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European\u2013Australasian Acute Stroke Study Investigators","volume":"352","author":"Hacke","year":"1998","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.hoc.2004.09.008_bib79","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.282.21.2019","article-title":"Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke","volume":"282","author":"Clark","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.hoc.2004.09.008_bib80","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/01.STR.31.4.811","article-title":"The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Thrombolytic therapy in acute ischemic stroke study investigators","volume":"31","author":"Clark","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.hoc.2004.09.008_bib81","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(95)92049-8","article-title":"Randomized controlled trial of streptokinase, aspirin and combination of both in treatment of acute ischemic stroke","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2004.09.008_bib82","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.1996.03540120039031","article-title":"Streptokinase for acute ischemic stroke with relationship to time of admission","volume":"276","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2004.09.008_bib83","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM199607183350301","article-title":"Thrombolytic therapy with streptokinase in acute ischemic stroke","volume":"335","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2004.09.008_bib84","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.STR.29.1.4","article-title":"PROACT: a phase II randomized trial of recombinant prourokinase by direct delivery in acute middle cerebral artery stroke","volume":"29","author":"del Zoppo","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.hoc.2004.09.008_bib85","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","article-title":"A randomized trial of intra-arterial prourokinase for acute ishemic stroke due to middle cerebral artery occlusion","volume":"282","author":"Furlan","year":"1999","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2004.09.008_bib86","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.3949\/ccjm.71.Suppl_1.S31","article-title":"Intra-arterial thrombolysis for acute stroke","volume":"71","author":"Furlan","year":"2004","journal-title":"Cleve Clin J Med"},{"issue":"6","key":"10.1016\/j.hoc.2004.09.008_bib87","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/jnnp.2003.020479","article-title":"Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis","volume":"75","author":"Arnold","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.hoc.2004.09.008_bib88","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1161\/01.STR.30.12.2598","article-title":"Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy iof acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial","volume":"30","author":"Lewandowski","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.hoc.2004.09.008_bib89","first-page":"359","article-title":"Combined IV\u2013IA rtPA treatment in major ischemic stroke [abstract]","volume":"33","author":"Tomsick","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.hoc.2004.09.008_bib90","first-page":"352","article-title":"Combined intraarterial\/intravenous thrombolysis fro acute ischemic stroke","volume":"22","author":"Keris","year":"2001","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib91","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1051-0443(07)61984-8","article-title":"Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study","volume":"13","author":"Lee","year":"2002","journal-title":"J Vasc Interv Radiol"},{"issue":"1 Pt 2","key":"10.1016\/j.hoc.2004.09.008_bib92","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/01.RVI.0000107490.61085.10","article-title":"Intraarterial thrombolysis trials in acute ischemic stroke","volume":"15","author":"Ng","year":"2004","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"10.1016\/j.hoc.2004.09.008_bib93","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1227\/01.NEU.0000097197.61376.05","article-title":"Intraarterial thrombolytic therapy within 3 hours of the onset of stroke","volume":"54","author":"Bourekas","year":"2004","journal-title":"Neurosurgery"},{"issue":"9078","key":"10.1016\/j.hoc.2004.09.008_bib94","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(97)03022-5","article-title":"Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke","volume":"350","author":"Wardlaw","year":"1997","journal-title":"Lancet"},{"issue":"7 Suppl 4","key":"10.1016\/j.hoc.2004.09.008_bib95","first-page":"S3","article-title":"Thrombolysis in acute ischemic stroke: controlled trials and clinical experience","volume":"53","author":"Hacke","year":"1999","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.hoc.2004.09.008_bib96","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1161\/01.STR.0000101752.23813.C3","article-title":"Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data","volume":"34","author":"Graham","year":"2003","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.hoc.2004.09.008_bib97","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00019052-200402000-00012","article-title":"An update on thrombolytic therapy for acute stroke","volume":"17","author":"Schellinger","year":"2004","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"10.1016\/j.hoc.2004.09.008_bib98","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ana.10781","article-title":"Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: insights into the pathophysiology of acute stroke in the thrombolysis era","volume":"55","author":"Chalela","year":"2004","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.hoc.2004.09.008_bib99","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/01.STR.0000117094.41638.EE","article-title":"Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion","volume":"35","author":"Straub","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.hoc.2004.09.008_bib100","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1001\/jama.283.23.3102","article-title":"Recommendations for the establishment of primary stroke centers: Brain Attack Coalition","volume":"283","author":"Alberts","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2004.09.008_bib101","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1017\/S0317167100034120","article-title":"Canadian guidelines for intravenous thrombolytic treatment in acute stroke: a consensus statement of the Canadian Stroke Consortium","volume":"25","author":"Norris","year":"1998","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.hoc.2004.09.008_bib102","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2796.1996.39861000.x","article-title":"Stroke management in Europe: Pan European Consensus Meeting on Stroke Management","volume":"240","author":"Aboderin","year":"1996","journal-title":"J Intern Med"},{"key":"10.1016\/j.hoc.2004.09.008_bib103","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/WNL.47.2.366","article-title":"Early CT signs in acute middle cerebral artery infarction: predictive value for subsequent infarct locations and outcome","volume":"47","author":"Moulin","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.hoc.2004.09.008_bib104","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00593212","article-title":"Detectability of cerebral hemisphere ischaemic infarcts by CT within 6 h of stroke","volume":"38","author":"von Kummer","year":"1996","journal-title":"Neuroradiology"},{"key":"10.1016\/j.hoc.2004.09.008_bib105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1148\/radiology.205.2.9356611","article-title":"Acute stroke: usefulness of early CT findings before thrombolytic therapy","volume":"205","author":"von Kummer","year":"1997","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.hoc.2004.09.008_bib106","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ageing\/afh064","article-title":"A systematic review of barriers to delivery of thrombolysis for acute stroke","volume":"33","author":"Kwan","year":"2004","journal-title":"Age Ageing"},{"key":"10.1016\/j.hoc.2004.09.008_bib107","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1001\/jama.1970.03180120035007","article-title":"Urokinase pulmonary embolism trial","volume":"214","author":"Bell","year":"1970","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2004.09.008_bib108","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1001\/jama.1974.03230500024021","article-title":"Urokinase-streptokinase embolism trial, phase 2 results","volume":"229","author":"Bell","year":"1974","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.hoc.2004.09.008_bib109","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7326\/0003-4819-90-5-802","article-title":"The use of thrombolytic agents: choice of patient, drug administration, laboratory monitoring","volume":"90","author":"Marder","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hoc.2004.09.008_bib110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(88)92354-9","article-title":"Randomized controlled trial of recombinant tissue plasminogen activator versus urokinase in th treatment of acute pulmonary embolism","volume":"2","author":"Goldhaber","year":"1988","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.hoc.2004.09.008_bib111","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0002-9343(90)90148-7","article-title":"Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis","volume":"88","author":"Goldhaber","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.hoc.2004.09.008_bib112","first-page":"537","article-title":"The post-phlebitic syndrome. Pathophysiology prevention and management","volume":"5","author":"Immelman","year":"1984","journal-title":"Clin Chest Med"},{"issue":"1\u20132","key":"10.1016\/j.hoc.2004.09.008_bib113","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.0954-6820.1982.tb01904.x","article-title":"Streptokinase of heparin in the treatment of deep vein thrombosis. Follow-up results of a prospective study","volume":"211","author":"Arnesen","year":"1982","journal-title":"Acta Med Scand"},{"issue":"12","key":"10.1016\/j.hoc.2004.09.008_bib114","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/bjs.1800661203","article-title":"A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: an interim report of a prospective trial","volume":"66","author":"Elliot","year":"1979","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.hoc.2004.09.008_bib115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.0954-6820.1979.tb06050.x","article-title":"Rapid thrombolysis and preservation of valvular venous function in high deep vein thrombosis. A comparative study between streptokinase and heparin therapy","volume":"205","author":"Watz","year":"1979","journal-title":"Acta Med Scand"},{"issue":"11","key":"10.1016\/j.hoc.2004.09.008_bib116","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/000331977602701105","article-title":"Deep vein thrombosis treated with streptokinase or heparin. Follow-up of a randomized study","volume":"27","author":"Common","year":"1976","journal-title":"Angiology"},{"issue":"1\u20132","key":"10.1016\/j.hoc.2004.09.008_bib117","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.0954-6820.1979.tb13475.x","article-title":"Comparison of streptokinase with heparin: late results in the treatment of deep venous thrombosis","volume":"206","author":"Johansson","year":"1979","journal-title":"Acta Med Scand"},{"issue":"4A","key":"10.1016\/j.hoc.2004.09.008_bib118","first-page":"54","article-title":"Hemodynamic and clinical assessment after therapy for acute deep vein thrombosis. A prospective study","volume":"150","author":"Kakkar","year":"1985","journal-title":"Am J Surg"},{"key":"10.1016\/j.hoc.2004.09.008_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-125-1-199607010-00001","article-title":"The long-term clinical course of acute deep venous thrombosis","volume":"125","author":"Prandoni","year":"1996","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.hoc.2004.09.008_bib120","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0025-7125(03)00112-3","article-title":"Young patients with iliofemoral deep venous thrombosis should receive thrombolytic therapy","volume":"87","author":"Navarro","year":"2003","journal-title":"Med Clin North Am"},{"issue":"Suppl 4","key":"10.1016\/j.hoc.2004.09.008_bib121","first-page":"172S","article-title":"Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial","volume":"97","author":"Turpie","year":"1990","journal-title":"Chest"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2004.09.008_bib122","doi-asserted-by":"crossref","first-page":"176S","DOI":"10.1378\/chest.119.1_suppl.176S","article-title":"Antithrombotic therapy for venous thromboembolic disease","volume":"119","author":"Hyers","year":"2001","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.hoc.2004.09.008_bib123","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0741-5214(94)90012-4","article-title":"A strategy of aggressive regional therapy for acute iliofemoral venous thrombosis with contemporary venous thrombectomy or catheter-directed thrombolysis","volume":"20","author":"Comerota","year":"1994","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1016\/j.hoc.2004.09.008_bib124","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1148\/radiology.191.2.8153327","article-title":"Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis","volume":"191","author":"Semba","year":"1994","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.hoc.2004.09.008_bib125","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-2001-14549","article-title":"Endovascular local thrombolytic therapy of ileofemoral and inferior caval vein thrombosis","volume":"1","author":"Verhaeghe","year":"2001","journal-title":"Semin Vasc Med"},{"issue":"3","key":"10.1016\/j.hoc.2004.09.008_bib126","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1051-0443(97)70581-5","article-title":"Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy","volume":"8","author":"Bjarnason","year":"1997","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"10.1016\/j.hoc.2004.09.008_bib127","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1148\/radiology.211.1.r99ap4739","article-title":"Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry","volume":"211","author":"Mewissen","year":"1999","journal-title":"Radiology"},{"issue":"23","key":"10.1016\/j.hoc.2004.09.008_bib128","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1056\/NEJM198806093182306","article-title":"Thrombolytic therapy: current status","volume":"318","author":"Marder","year":"1988","journal-title":"N Engl J Med"},{"issue":"8844","key":"10.1016\/j.hoc.2004.09.008_bib129","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0140-6736(93)90274-K","article-title":"Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion","volume":"341","author":"Goldhaber","year":"1993","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.hoc.2004.09.008_bib130","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1378\/chest.106.3.718","article-title":"Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group","volume":"106","author":"Goldhaber","year":"1994","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.hoc.2004.09.008_bib131","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0735-1097(98)00068-0","article-title":"Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up","volume":"31","author":"Meneveau","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.hoc.2004.09.008_bib132","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0002-9149(98)00513-X","article-title":"Comparison of alteplase versus heparin for resolution of major pulmonary embolism","volume":"82","author":"Konstantinides","year":"1998","journal-title":"Am J Cardiol"},{"issue":"15","key":"10.1016\/j.hoc.2004.09.008_bib133","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJM198010093031502","article-title":"Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism","volume":"303","author":"Sharma","year":"1980","journal-title":"N Engl J Med"},{"issue":"1 Pt 1","key":"10.1016\/j.hoc.2004.09.008_bib134","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-8703(99)70243-7","article-title":"Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism","volume":"138","author":"Tebbe","year":"1999","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.hoc.2004.09.008_bib135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1098-3597(00)90013-9","article-title":"Management of deep vein thrombosis and pulmonary embolism","volume":"2","author":"Goldhaber","year":"2000","journal-title":"Clin Cornerstone"},{"key":"10.1016\/j.hoc.2004.09.008_bib136","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s003300050776","article-title":"Percutaneous catheter and guidewire fragmentation with local administration of recombinant tissue plasminogen activator as a treatment for massive pulmonary embolism","volume":"9","author":"Murphy","year":"1999","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.hoc.2004.09.008_bib137","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.CIR.77.2.353","article-title":"Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism","volume":"77","author":"Verstraete","year":"1988","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.hoc.2004.09.008_bib138","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1001\/archinte.1997.00440430026003","article-title":"Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?","volume":"157","author":"Dalen","year":"1997","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.hoc.2004.09.008_bib139","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9149(96)00339-6","article-title":"Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism","volume":"78","author":"McConnell","year":"1996","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.hoc.2004.09.008_bib140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-2001-18490","article-title":"Thrombolytic therapy in pulmonary embolism","volume":"1","author":"Goldhaber","year":"2001","journal-title":"Semin Vasc Med"},{"key":"10.1016\/j.hoc.2004.09.008_bib141","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMp020107","article-title":"Thrombolysis for pulmonary embolism","volume":"347","author":"Goldhaber","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2004.09.008_bib142","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.93.12.2212","article-title":"Management of deep vein thrombosis and pulmonary embolism: a statement for healthcare professionals","volume":"93","author":"Hirsh","year":"1996","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hoc.2004.09.008_bib143","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/j.1875-9114.1994.tb02860.x","article-title":"Thrombolytic therapy for pulmonary embolism: reversal of shock in the early postoperative period","volume":"14","author":"Nasraway","year":"1994","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.hoc.2004.09.008_bib144","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0090-3019(94)90074-4","article-title":"Urokinase thrombolytic therapy of pulmonary embolism in neurosurgically treated patients","volume":"42","author":"Severi","year":"1994","journal-title":"Surg Neurol"},{"issue":"9","key":"10.1016\/j.hoc.2004.09.008_bib145","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/oxfordjournals.eurheartj.a060666","article-title":"Massive pulmonary embolism in pregnancy treated with streptokinase and percutaneous catheter fragmentation","volume":"15","author":"Mazeka","year":"1994","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.hoc.2004.09.008_bib146","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1001\/archinte.160.10.1529","article-title":"Pulmonary embolism as a cause of cardiac arrest: presentation and outcome","volume":"160","author":"Kurkciyan","year":"2000","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.hoc.2004.09.008_bib147","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1378\/chest.106.4.1281","article-title":"High-dose bolus injection of urokinase. Use during cardiopulmonary resuscitation for massive pulmonary embolism","volume":"106","author":"Bottinger","year":"1994","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.hoc.2004.09.008_bib148","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0735-1097(00)00734-8","article-title":"Massive pulmonary embolism: percutaneous emergency treatment by pigtail rotation catheter","volume":"36","author":"Schmitz-Rode","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.hoc.2004.09.008_bib149","first-page":"495","article-title":"Major pulmonary embolism and shock. Persistent hypotension after thrombolysis treated with improvised mechanical fragmentation of thrombus","volume":"179","author":"Lapanum","year":"2003","journal-title":"Med J Aust"},{"key":"10.1016\/j.hoc.2004.09.008_bib150","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1538-7836.2003.00335.x","article-title":"Thrombolysis in submassive pulmonary embolism? Yes","volume":"1","author":"Konstantinides","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.hoc.2004.09.008_bib151","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1046\/j.1538-7836.2003.00343.x","article-title":"Thrombolysis in submassive pulmonary embolism? No","volume":"1","author":"Dalen","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.hoc.2004.09.008_bib152","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0735-1097(97)00319-7","article-title":"Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry","volume":"30","author":"Kasper","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib153","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1161\/01.CIR.96.3.882","article-title":"Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism","volume":"96","author":"Konstantinides","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib154","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMoa021274","article-title":"Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism","volume":"347","author":"Konstantinides","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.hoc.2004.09.008_bib155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00129784-200404020-00001","article-title":"Should thrombolytic therapy be used in patients with pulmonary embolism?","volume":"4","author":"Konstantinides","year":"2004","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.hoc.2004.09.008_bib156","first-page":"1905","article-title":"A comparison of heparin plus full, bolus dose reteplase with half-dose reteplase plus abciximab plus heparin in patients with acute myocardial infarction","volume":"357","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2004.09.008_bib157","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1056\/NEJM199406303302605","article-title":"A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis","volume":"330","author":"O'Meara","year":"1994","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.hoc.2004.09.008_bib158","doi-asserted-by":"crossref","first-page":"377","DOI":"10.7326\/0003-4819-74-3-377","article-title":"The effect of streptokinase infusion on chronic arterial occlusions and stenoses","volume":"74","author":"Verstraete","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hoc.2004.09.008_bib159","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(62)90786-9","article-title":"Popliteal artery thrombosis treated with streptokinase","volume":"2","author":"Cotton","year":"1962","journal-title":"Lancet"},{"issue":"736","key":"10.1016\/j.hoc.2004.09.008_bib160","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bmj.4.5736.639","article-title":"Outcome of recent thromboembolic occlusions of limb arteries treated with streptokinase","volume":"4","author":"Amery","year":"1970","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.hoc.2004.09.008_bib161","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0741-5214(85)90176-4","article-title":"Thrombolytic therapy for acute arterial occlusion","volume":"2","author":"Sicard","year":"1985","journal-title":"J Vasc Surg"},{"issue":"5","key":"10.1016\/j.hoc.2004.09.008_bib162","first-page":"431","article-title":"Statistical determinants of success and complications of thrombolytic therapy for arterial occlusion of lower extremity","volume":"161","author":"Hallett","year":"1985","journal-title":"Surg Gynecol Obstet"},{"issue":"17","key":"10.1016\/j.hoc.2004.09.008_bib163","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1001\/jama.1982.03320420047031","article-title":"Selective intra-arterial streptokinase therapy in the immediate postoperative period","volume":"247","author":"Chaise","year":"1982","journal-title":"JAMA"},{"issue":"26","key":"10.1016\/j.hoc.2004.09.008_bib164","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM198212233072606","article-title":"Local low-dose thrombolytic therapy of peripheral arterial occlusions","volume":"307","author":"Hess","year":"1982","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.hoc.2004.09.008_bib165","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00000658-198308000-00013","article-title":"Streptokinase treatment of acute arterial occlusion","volume":"198","author":"Berni","year":"1983","journal-title":"Ann Surg"},{"key":"10.1016\/j.hoc.2004.09.008_bib166","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM199804163381603","article-title":"Investigators for the Thrombolysis or Peripheral Artery Surgery (TOPAS). A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs","volume":"338","author":"Ouriel","year":"1998","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.hoc.2004.09.008_bib167","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0741-5214(94)70214-4","article-title":"A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia","volume":"19","author":"Ouriel","year":"1994","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.hoc.2004.09.008_bib168","first-page":"207","article-title":"Thrombolysis in the management of lower limb peripheral arterial occlusion: a consensus document","volume":"81","year":"1998","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.hoc.2004.09.008_bib169","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2214\/ajr.144.4.769","article-title":"Thrombolysis of peripheral arterial and graft occlusions: improved results using high-dose urokinase","volume":"144","author":"McNamara","year":"1985","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.hoc.2004.09.008_bib170","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0741-5214(05)80036-9","article-title":"Thrombolysis or peripheral arterial surgery: phase I results. TOPAS Investigators","volume":"23","author":"Ouriel","year":"1996","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.hoc.2004.09.008_bib171","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archsurg.1994.01420320087017","article-title":"Peripheral thrombolysis with tissue plasminogen activator: results of two treatment regimens","volume":"129","author":"Ward","year":"1994","journal-title":"Arch Surg"},{"key":"10.1016\/j.hoc.2004.09.008_bib172","first-page":"646","article-title":"Prospective randomized trial of high-dose versus low-dose tissue plasminogen activator infusion in the management of acute limb ischemia","volume":"84","author":"Braithwaite","year":"1997","journal-title":"Br J Surg"},{"key":"10.1016\/j.hoc.2004.09.008_bib173","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1051-0443(07)61799-0","article-title":"Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study","volume":"11","author":"Ouriel","year":"2000","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib174","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1051-0443(07)61949-6","article-title":"Declining-dose study of reteplase treatment for lower extremity arterial occlusions","volume":"13","author":"Castaneda","year":"2002","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib175","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/152660280100800618","article-title":"Recombinant tissue plasminogen activator versus urokinase for local thrombolysis of femoropopliteal occlusions: a prospective, randomized multicenter trial","volume":"8","author":"Mahler","year":"2001","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.hoc.2004.09.008_bib176","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00000658-199409000-00003","article-title":"Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE Trial","volume":"220","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.hoc.2004.09.008_bib177","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1051-0443(07)61419-5","article-title":"Initial results of reteplase in the treatment of acute lower extremity arterial occlusions","volume":"11","author":"Davidian","year":"2000","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib178","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S1051-0443(07)61650-9","article-title":"Catheter-directed thrombolysis in deep venous thrombosis with the use of reteplase: immediate results and complications from a pilot study","volume":"13","author":"Castaneda","year":"2002","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib179","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/152660280200900508","article-title":"Initial clinical results of tenecteplase (TNK) in catheter-directed thrombolytic therapy","volume":"9","author":"Razavi","year":"2002","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.hoc.2004.09.008_bib180","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S1051-0443(07)61950-2","article-title":"Thrombolysis of occluded peripheral arteries and veins with tenecteplase: a pilot study","volume":"13","author":"Burkart","year":"2002","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib181","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1051-0443(07)61476-6","article-title":"SCVIR reporting standards for the treatment of acute limb ischemia with the use of transluminal removal of arterial thrombus","volume":"12","author":"Patel","year":"2001","journal-title":"J Vasc Interv Radiol"},{"issue":"11","key":"10.1016\/j.hoc.2004.09.008_bib182","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s00415-003-0173-6","article-title":"Good outcome in early pregnancy following direct thrombolysis for cerebral venous sinus thrombosis","volume":"250","author":"Weatherby","year":"2003","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.hoc.2004.09.008_bib183","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1345\/aph.17108","article-title":"Urokinase in the treatment of intraventricular hemorrhage","volume":"32","author":"Murry","year":"1998","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.hoc.2004.09.008_bib184","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1227\/01.NEU.0000103488.94855.4F","article-title":"Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis","volume":"54","author":"Amin-Hanjani","year":"2004","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.hoc.2004.09.008_bib185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1067\/mva.2000.107313","article-title":"Surgical intervention is not required for all patients with subclavian vein thrombosis","volume":"32","author":"Lee","year":"2000","journal-title":"J Vasc Surg"},{"issue":"6","key":"10.1016\/j.hoc.2004.09.008_bib186","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0003-4975(00)01151-6","article-title":"Paget-Schroetter syndrome: what is the best management?","volume":"69","author":"Urschel","year":"2000","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.hoc.2004.09.008_bib187","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1046\/j.1365-2141.1998.00860.x","article-title":"Budd-Chiari syndrome, portal vein and mesenteric vein thrombosis in a patient homozygous for factor V Leiden mutation treated by TIPS and thrombolysis","volume":"102","author":"Leebeek","year":"1998","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.hoc.2004.09.008_bib188","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1097\/00007890-200005270-00042","article-title":"Percutaneous portal vein thrombolysis and endovascular stent for management of post transplant portal venous conduit thrombosis","volume":"69","author":"Bhattacharjya","year":"2000","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.hoc.2004.09.008_bib189","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0741-5214(03)01052-8","article-title":"Treatment of portal venous thrombosis with selective superior mesenteric artery infusion of recombinant tissue plasminogen activator","volume":"38","author":"Henao","year":"2003","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.hoc.2004.09.008_bib190","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.CIR.87.1.30","article-title":"The St. Jude valve. Thrombolysis as the first line of therapy for cardiac valve thrombosis","volume":"87","author":"Silber","year":"1993","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.hoc.2004.09.008_bib191","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/S0735-1097(00)00640-9","article-title":"Thrombolysis is an effective and safe therapy in stuck bileaflet mitral valves in the absence of high-risk thrombi","volume":"35","author":"Shapira","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib192","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0735-1097(02)02872-3","article-title":"Fibrinolysis of mechanical prosthetic valve thrombosis: a single center study of 127 cases","volume":"41","author":"Roudaut","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hoc.2004.09.008_bib193","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jtcvs.2003.12.013","article-title":"Prosthetic valve thrombosis: twenty-year experience at the Montreal Heart Institute","volume":"127","author":"Durrleman","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.hoc.2004.09.008_bib194","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/B:THRO.0000003324.54575.1f","article-title":"Local thrombolytic therapy in cancer patients with central venous catheter occlusion in urgent need of antiblastic treatment: a single institution experience","volume":"15","author":"Agazzi","year":"2003","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.hoc.2004.09.008_bib195","series-title":"Hemostasis and thrombosis: basic principles and clinical practice","first-page":"1475","article-title":"Thrombolytic therapy: foundations and results","author":"Marder","year":"2001"},{"key":"10.1016\/j.hoc.2004.09.008_bib196","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1161\/01.CIR.92.10.2811","article-title":"Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-1 trial. Global Use of Strategies to Open Occluded Coronary Artery","volume":"92","author":"Gore","year":"1995","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hoc.2004.09.008_bib197","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.amjcard.2003.10.043","article-title":"Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial)","volume":"93","author":"Kandzari","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib198","series-title":"Thrombosis and hemorrhage","first-page":"1215","article-title":"Pharmacology of thrombolytic agents","author":"Leopold","year":"1998"},{"key":"10.1016\/j.hoc.2004.09.008_bib199","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0140-6736(95)92224-5","article-title":"Randomized, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence","volume":"346","year":"1995","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.hoc.2004.09.008_bib200","doi-asserted-by":"crossref","first-page":"597","DOI":"10.7326\/0003-4819-129-8-199810150-00002","article-title":"Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2","volume":"129","author":"Gurwitz","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hoc.2004.09.008_bib201","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/0735-1097(94)90163-5","article-title":"Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial","volume":"24","author":"Cannon","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib202","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1161\/01.CIR.91.11.2725","article-title":"More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction","volume":"91","author":"Smalling","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib203","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.CIR.95.2.351","article-title":"TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombloysis in Myocardial infarction (TIMI) 10. A dose-ranging trial","volume":"95","author":"Cannon","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib204","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","article-title":"Thrombolysis in Myocardial Infarction (TIMI) trial phase I findings","volume":"312","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2004.09.008_bib205","first-page":"65","article-title":"GISSI-2: a factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction","volume":"336","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2004.09.008_bib206","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0140-6736(92)91893-D","article-title":"ISIS3: a randomized comparison of streptokinase versus tissue plasminogen activator versus anistreplase and of aspirin plus heparin versus aspirin alone among 14,299 cases of suspected acute myocardial infarction","volume":"339","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2004.09.008_bib207","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJM199311253292204","article-title":"The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2004.09.008_bib208","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/01.CIR.94.5.891","article-title":"Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction","volume":"94","author":"Bode","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib209","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJM199710163371603","article-title":"A comparison of reteplase with alteplase for acute myocardial infarction","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2004.09.008_bib210","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0735-1097(93)90041-X","article-title":"Profound inhibition of platelet aggregation with monoclonal antibody 7E3 fab following thrombolytic therapy: results of the TAMI 8 pilot study","volume":"22","author":"Kleiman","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib211","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1161\/01.CIR.101.24.2788","article-title":"Trial of abciximab with and without low-dose reteplase for acute myocardial infarction: Strategies for Patency Enhancement in the Emergency Department (SPEED)","volume":"101","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib212","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(01)05775-0","article-title":"Efficacy and safety of tenecteplase in combination with enoxaparin, abcixmab, or unfractionated heparin: the ASSENT-3 randomized trial in acute myocardial infarction","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2004.09.008_bib213","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0735-1097(01)01758-2","article-title":"Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction. The Integrilin and Low-Dose Thrombolysis in Acute Myocardial Infraction (INTRO-AMI) trial","volume":"39","author":"Brener","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib214","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0735-1097(03)00123-2","article-title":"Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction. Results of the Integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) phase II angiographic trial","volume":"41","author":"Giugliano","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.hoc.2004.09.008_bib215","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1161\/01.CIR.99.21.2720","article-title":"Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators","volume":"99","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib216","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1053\/euhj.2000.2498","article-title":"Intravenous NPA for the treatment of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute mycardial infarction","volume":"21","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hoc.2004.09.008_bib217","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0195-668X(03)00006-X","article-title":"Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study","volume":"24","author":"Wallentin","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hoc.2004.09.008_bib218","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1053\/euhj.2001.3083","article-title":"Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction. The AMI-SK study","volume":"23","author":"Simoons","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hoc.2004.09.008_bib219","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1161\/hc3101.093866","article-title":"Randomized comparison of enoxaparin, a low- molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II)","volume":"104","author":"Ross","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0002-9149(99)80517-7","article-title":"Initial experience with hirudin and streptokinase in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 6 trial","volume":"75","author":"Lee","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hoc.2004.09.008_bib221","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/01.CIR.94.5.911","article-title":"Hirudin in acute myocardial infarction: Thrombolysis and Thrombin in Myocardial Infarction (TIMI) 9b trial","volume":"94","author":"Antman","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib222","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1161\/01.CIR.90.4.1638","article-title":"Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HITT-III) study: a study of the Arbeirsgemeinschaft Leitender Kardiologischer Krankenhausarzte (ALKK)","volume":"90","author":"Neuhaus","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2004.09.008_bib223","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0140-6736(01)06887-8","article-title":"Thrombin-specific anticoagulation with bivalrudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: The HERO-2 randomized trial","volume":"358","year":"2001","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.hoc.2004.09.008_bib224","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1161\/01.CIR.100.15.1609","volume":"100","author":"Zhao","year":"1999","journal-title":"Circulation"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858804001170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858804001170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:37:14Z","timestamp":1760182634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858804001170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":224,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0889858804001170"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2004.09.008","relation":{},"ISSN":["0889-8588"],"issn-type":[{"type":"print","value":"0889-8588"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombolytic Therapy: Current Clinical Practice","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2004.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}